RudaCure Inc. attends the Global Bio Expo BIO USA 2024
RudaCure Inc. (hereinafter "RudaCure"), a company specializing in the development of treatments for ocular diseases and chronic pain, attended the 'BIO International Convention 2024' (hereinafter "BIO USA") held in San Diego, USA from June 3 to June 6. BIO USA is the world's largest biotechnology industry expo, offering a comprehensive view of the latest trends and innovative technologies in the global bio industry.
At this expo, RudaCure showcased its latest R&D achievements and technological capabilities while exploring opportunities to build global partnerships and collaborations. In particular, RudaCure's key products—dry eye disease treatment (RCI001) and corneal ulcer treatment (RCI001U)—drew significant attention from attendees.
Throughout the event, RudaCure conducted business meetings with a variety of global pharmaceutical and biotech companies, engaging in discussions on technology transfer and joint R&D. Through these interactions, RudaCure aims to strengthen its position in the global market and enhance its international competitiveness.
RudaCure plans to grow into a global biopharmaceutical company that contributes to improving human health and quality of life through continuous R&D and innovation. This participation in BIO USA is expected to further solidify RudaCure's standing in the global bio market and mark an important turning point for the company's future growth.